The estimated Net Worth of Michael David Staffieri is at least $46.6 Million dollars as of 15 August 2024. Mr Staffieri owns over 42,119 units of DaVita Inc stock worth over $32,240,116 and over the last 11 years he sold DVA stock worth over $11,434,058. In addition, he makes $2,882,427 as Chief Operating Officer of Kidney Care at DaVita Inc.
Mr has made over 20 trades of the DaVita Inc stock since 2014, according to the Form 4 filled with the SEC. Most recently he sold 42,119 units of DVA stock worth $6,323,325 on 15 August 2024.
The largest trade he's ever made was exercising 243,994 units of DaVita Inc stock on 10 May 2023 worth over $16,174,362. On average, Mr trades about 28,457 units every 111 days since 2014. As of 15 August 2024 he still owns at least 209,365 units of DaVita Inc stock.
You can see the complete history of Mr Staffieri stock trades at the bottom of the page.
Michael David Staffieri is the Chief Operating Officer of Kidney Care at DaVita Inc.
As the Chief Operating Officer of Kidney Care of DaVita Inc, the total compensation of Mr Staffieri at DaVita Inc is $2,882,427. There are 6 executives at DaVita Inc getting paid more, with Javier Rodriguez having the highest compensation of $16,853,500.
Mr Staffieri is 47, he's been the Chief Operating Officer of Kidney Care of DaVita Inc since . There are 18 older and 2 younger executives at DaVita Inc. The oldest executive at DaVita Inc is John Nehra, 71, who is the Independent Director.
Michael's mailing address filed with the SEC is C/O DAVITA INC., 2000 16TH STREET, DENVER, CO, 80202.
Over the last 22 years, insiders at DaVita Inc have traded over $539,813,199 worth of DaVita Inc stock and bought 20,841,023 units worth $1,590,012,094 . The most active insiders traders include Hathaway Incbuffett Warren ..., R. Ted Weschler,, and Kent J Thiry. On average, DaVita Inc executives and independent directors trade stock every 12 days with the average trade being worth of $12,626,872. The most recent stock trade was executed by Kathleen Alyce Waters on 28 August 2024, trading 26,333 units of DVA stock currently worth $1,999,991.
about davita kidney care davita kidney care is a division of davita healthcare partners inc., a fortune 500® company that, through its operating divisions, provides a variety of health care services to patient populations throughout the united states and abroad. a leading provider of dialysis services in the united states, davita kidney care treats patients with chronic kidney failure and end stage renal disease. davita kidney care strives to improve patients' quality of life by innovating clinical care, and by offering integrated treatment plans, personalized care teams and convenient health-management services. as of march 31, 2015, davita kidney care operated or provided administrative services at 2,197 outpatient dialysis centers located in the united states serving approximately 174,000 patients. the company also operated 93 outpatient dialysis centers located in 10 countries outside the united states. davita kidney care supports numerous programs dedicated to creating positive,
DaVita Inc executives and other stock owners filed with the SEC include: